Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perampanel for Alcohol Dependence
NCT02120365Phase 2Completed
- Sponsor
- Virginia Commonwealth University
- Start
- Jun 2019
- Primary completion
- Feb 2022
- Modality
- Classical Binding Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of perampanel in alcohol use disorder (AUD) (3 arms), sponsored by Virginia Commonwealth University. Primary endpoints: Biphasic Alcohol Effects Scale Stimulant Subscale at 98 minutes, Biphasic Alcohol Effects Scale Sedative Subscale at 98 minutes and 1 more. Started Jun 2019; status: completed.
02
Drugs
perampanel
03
Conditions
alcohol use disorder (AUD)
Beyond the preview
Go deeper on NCT02120365.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02120365.